The MOLLI 2 System provides a wire-free and radiation-free approach to localising lesions for breast cancer surgery. Credit: Ground Picture / Shutterstock.

The Medical University of South Carolina (MUSC) Hollings Cancer Center in the US is set to deploy MOLLI Surgical’s advanced breast cancer technology, the MOLLI 2 System.

The technology is designed to improve the patient experience and surgical outcomes with its wire-free and radiation-free approach to localising lesions for breast cancer surgery.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It allows radiologists to mark lesions using the MOLLI Marker, a small localisation device that can be placed up to 30 days before surgery.

This flexibility allows radiologists to optimise their time without the need to coordinate with surgical schedules. Surgeons then use the MOLLI Wand and MOLLI Tablet for reliable lesion detection, which eliminates the traditional wire-guided localisation method.

Hollings Comprehensive Breast Program medical director and surgical oncologist Andrea Abbott said: “MOLLI 2 provides precise feedback while localising the lesion; the information is instantaneous and allows for efficiency and accuracy.

“And patients appreciate the flexibility of having the MOLLI Marker placed ahead of time instead of adding another procedure to the day of surgery.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Designed to offer directional 3D guidance, the technology provides surgeons with millimeter precision in locating the marked lesion.

The MOLLI 2 System’s ease of use, reliability, and precision contribute to increased efficiency and an enhanced patient experience.

The integration of the system into the existing workflows and operating rooms at Hollings has been seamless, MOLLI Surgical said.

MOLLI Surgical president and CEO Ananth Ravi said: “MUSC makes a profound impact on its community as the state’s only comprehensive academic health system. Given its wide reach to patients and medical students, we’re honoured to be selected as a partner to provide precision surgery solutions.

“MUSC’s dedication to advancing patient-centric breast cancer care is further affirmed by their adoption of MOLLI 2.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact